ArticleBreast cancer research : BCR2015

BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.

Zannel Blanchard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.